FY26 and Q4 operational update FY26 Highlights: • IPO completed in December 2025, providing sufficient funding to support commercialisation plans well into 2028, including commencement of full commercial sales of Minder ® . • Reached 50 patient enrolments in DETECT on 16 July 2026,...